Home › Funds › TCG Crossover Management, LLC › BHVN
TCG Crossover Management, LLC position in BHVN
BIOHAVEN LTD · Health Care
TCG Crossover Management, LLC reported holding 1,779,952 shares of BHVN (BIOHAVEN LTD) in its Q2 2026 13F filing — a position valued at US$26.5M, representing 0.64% of its reported portfolio and ranking #38 among its reported holdings. TCG Crossover Management, LLC has disclosed BHVN holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How TCG Crossover Management, LLC's BHVN position evolved
TCG Crossover Management, LLC first disclosed a stake in BHVN in Q4 2025 at 4,631,317 shares (US$52.3M). Across 3 filings, TCG Crossover Management, LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 1,779,952 shares valued at US$26.5M — a reduction of -2,851,365 shares quarter over quarter.. Notable position changes include a 62% trim in Q2 2026 (shares fell 10% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 4.63M | $52.29M | New |
| Q1 2026 | 4.63M | $39.18M | Hold |
| Q2 2026 | 1.78M | $26.49M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BHVN and 13F data
BHVN (BIOHAVEN LTD) is a Health Care company. 29 other funds we track also report a position in BHVN — the largest reported positions include MONTANOVA CAPITAL, LLC (US$153.1M), INFINITUM ASSET MANAGEMENT, LLC (US$93.0M), Royalty Pharma Sub-Manager, LLC (US$43.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BHVN
- MONTANOVA CAPITAL, LLC 10.29M sh · $153.07M · Q2 2026
- INFINITUM ASSET MANAGEMENT, LLC 6.25M sh · $93.00M · Q2 2026
- Royalty Pharma Sub-Manager, LLC 2.94M sh · $43.70M · Q2 2026
- Cormorant Asset Management, LP 2.61M sh · $38.84M · Q2 2026
- Knoll Capital Management, LLC 2.35M sh · $35.01M · Q2 2026
- ARS Investment Partners, LLC 1.37M sh · $20.45M · Q2 2026
More on TCG Crossover Management, LLC
FAQ
How long has TCG Crossover Management, LLC held BHVN?
TCG Crossover Management, LLC has disclosed BHVN holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
What is TCG Crossover Management, LLC's current position in BHVN?
As of Q2 2026, TCG Crossover Management, LLC holds 1.78M shares of BHVN (BIOHAVEN LTD), valued at $26.49M, representing 0.64% of its reported portfolio and ranking #38.
Has TCG Crossover Management, LLC been buying or selling BHVN?
In the latest 13F filing (Q2 2026), TCG Crossover Management, LLC reduced its position in BHVN.
Which other funds hold BHVN?
Other major institutional holders of BHVN include MONTANOVA CAPITAL, LLC, INFINITUM ASSET MANAGEMENT, LLC, Royalty Pharma Sub-Manager, LLC, among 29 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.